The manufacturers say that
tenofovir (which may cause
renal impairment) has not been evaluated with
nephrotoxic drugs such as
ganciclovir (and therefore probably valganciclovir).
The manufacturers advise that if concurrent use is essential
renal function should be monitored at least weekly.